L&C Bio Co

L&C Bio Co Debt

The Debt of L&C Bio Co (290650.KQ) as of Oct 30, 2026 is 4.02 B KRW. In the previous year, Debt was 123.90 B KRW — a change of -96.76% (lower).

Debt

4.02 BKRW

YoY

-96.76%

Last updated:

In 2025, L&C Bio Co's total debt was 4.02 B KRW, a -96.76% change from the 123.90 B KRW total debt recorded in the previous year.

The L&C Bio Co Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt
Date
Debt
Jan 1, 2018
1.00 B KRW
Jan 1, 2019
1.79 B KRW
Jan 1, 2020
15.03 B KRW
Jan 1, 2021
6.83 B KRW
Jan 1, 2022
81.94 B KRW
Jan 1, 2023
82.13 B KRW
Jan 1, 2024
123.90 B KRW
Jan 1, 2025
4.02 B KRW
The L&C Bio Co Debt history
YEARDebtYoY
4.02 BKRW-96.76%
123.90 BKRW+50.85%
82.13 BKRW+0.23%
81.94 BKRW+1,099.60%
6.83 BKRW-54.56%
15.03 BKRW+739.36%
1.79 BKRW+79.10%
1.00 BKRW+115.98%
463.00 MKRW-86.88%
3.53 BKRW+12.49%
3.14 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

L&C Bio Co Stock analysis

What does L&C Bio Co do? L&C BIO Co., Ltd. generates revenue by manufacturing and selling human tissue transplant materials designed for tissue repair and filler applications. The company also produces and sells human tissue-based medical devices and Cosmeceuticals, which serve various surgical needs including vascular, plastic, and general surgeries. The firm operates as a developer of soft tissue, allografts, and medical devices, with its products utilized in multiple medical procedures. This business model focuses on providing essential biological materials and devices to the healthcare sector through its core product lines. L&C Bio Co is one of the most popular companies on Eulerpool.

Debt Details

Understanding L&C Bio Co's Debt Structure

L&C Bio Co's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing L&C Bio Co's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to L&C Bio Co’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in L&C Bio Co’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about L&C Bio Co stock

Debt of L&C Bio Co is 4.02 B KRW in 2025.

Debt of L&C Bio Co changed from 123.90 B KRW to 4.02 B KRW, representing a -96.76% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Debt L&C Bio Co since 2006 – with annual values, charts, and detailed analysis.

Debt's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Debt's L&C Bio Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — L&C Bio Co

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — L&C Bio Co